Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v8.i4.60
pages 351-360

Biotechnological Potential of Mushrooms: Drugs and Dye Production

Girish Tidke
Department of Biotechnology, Amravati Univarsity, Amravati, Maharashtra - 444602, Iindia
Mahendra K. Rai
Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra-444 602, India

RÉSUMÉ

Mushrooms are a new and emerging source of potent pharmaceutical products. Medicinal mushrooms are being used in countries such as China, Japan, Korea, India, and also Russia, and now Western countries have also realized the curative properties of mushrooms. Ganoderma lucidum, Lentinus edodes, Trametes versicolor, Schizophyllum commune, Flammulina velutipes, Pleurotus ostreatus, Agaricus bisporus, A. brasiliensis Pholiota nameko, Tricholoma matsutake, Auricularia auricula, and Grifola frondosa possess wide range of bioactivities, e.g., anticancerous, antibacterial, antiviral, antifungal, antidiabitic, and anti-inflammatory. These are also used in cardiovascular disorders. Usually, mushrooms are administered orally or intraperitoneally. Mushrooms are also used for the production of dyes. These include Agaricus spp., Coriolopsis spp., Daedalea sterioides, Ganoderma applanatum, G. curtissi, G. spruci, G. resupinacium, Hexagonia hirta, H. tenicis, Laetiporus sulphureus, Lenzites betulina, Lycoperdon imbricatum, Oxiporus corticola, Phaeolus schwenitzi, Polyporus alveolus, P. brumalis, and Schizopora spp. There is a need to screen these mushrooms for their bioactivity and also for dye production. The present review aims to discuss the therapeutic activity and dye-producing properties of mushrooms.


Articles with similar content:

Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Biological Responses from Grifola frondosa (Dick.: Fr.) S. F. Gray−Maitake (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 4
Cun Zhuang, Takashi Mizuno
Biotechnological Potential of Mushrooms: Drugs and Dye Production
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Girish Tidke, Mahendra K. Rai
Study of Antiprotozoal Activity and Mitogenic Effects Within Some Medicinal Mushrooms
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
S. H. Sisakyan, Susanna M. Badalyan